Exact Sciences Approves Accelerated Bonus and Equity Vesting for Executives Ahead of Abbott Merger
I'm PortAI, I can summarize articles.
Exact Sciences Corporation has approved accelerated bonus and equity vesting for its executives in connection with its merger with Abbott Laboratories. Executives will receive early vesting of their fiscal year 2025 bonuses, with performance set at 115% of target. CEO Kevin Conroy will get a bonus of $436,056 and 713,931 PSU shares, while CFO Jeff Elliott will receive $507,150 and 63,099 RSU shares. Payments may be clawed back under certain conditions, and additional payments are possible if performance exceeds targets.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments